Clinical Trial Update: Plasma Biomarkers P-DAC, V1

View source ↗

Summary

Update on a terminated clinical trial (P-DAC, V1) evaluating plasma biomarkers for pancreatic ductal adenocarcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Ductal Adenocarcinoma

Snippet

Sponsor: Cancer Trials Ireland | Conditions: Pancreatic Ductal Adenocarcinoma | Status: TERMINATED